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Abstract: - Cervical cancer ranks as the 2nd leading cause of cancer among Filipino women wherein 70% of cervical cancer cases 
worldwide is caused by the human papillomavirus also known as HPV. Because of this, the HPV vaccine was made to protect people 
from getting infected with the said virus. However, despite the vaccine’s availability, women still die from and are being diagnosed 
with cervical cancer every year. This may be due to other factors that could influence one’s decision to get vaccinated or not. The 
study aimed to determine the relationship between the level of knowledge of women ages 25-35 in Metro Manila on HPV and 
cervical cancer and their decision to get immunized with HPV vaccine. The study utilized a correlational approach in collecting and 
analysing the data. A total of 65 respondents were included in the study wherein all of these respondents fit the inclusion criteria of 
being healthy, Filipino women who are 25-35 years old, and permanently residing in Metro Manila. An online survey through Google 
forms was deployed online through different social media platforms such as Facebook, Instagram, Discord, and Twitter. The survey 
focused on testing the respondents’ knowledge on HPV, Cervical Cancer, and the HPV vaccine as well as asking about their 
disposition on HPV vaccination. The data from the study were subjected to Spearman’s rho correlation coefficient. The respondents 
are predominantly “knowledgeable” of HPV, Cervical cancer, and HPV immunization based on their recorded composite score 
(>50%) wherein more than half of the population were found to have high knowledge on HPV (98.5%), Cervical cancer (93.8%), 
and HPV vaccine (84.6%). Majority of the respondents (96.9%) also expressed their willingness to be inoculated with the HPV 
vaccine if it is available, contrary to those who are reluctant with acquiring the said vaccine (3.1%). There is no significant 
relationship (p>0.05) was found between the level of knowledge of women on HPV, cervical cancer, HPV immunization and their 
disposition on HPV vaccine acceptance. Results of this study showed that there was no correlation between the knowledge of the 
respondents on HPV, Cervical Cancer, and HPV Vaccine and their willingness to get inoculated with the HPV Vaccine. The findings 
of this study show that most of the respondents are knowledgeable about HPV, cervical cancer and the HPV vaccine. The majority 
of the participants are also willing to take the HPV vaccine if it is available to them. Several limitations that may have contributed 
to the results and findings of this study include the use of convenience sampling and the limited number of respondents. This study 
is expected to provide information regarding HPV and Cervical cancer which may be beneficial in strengthening, promoting and 
implementing programs that are related to cervical cancer prevention and awareness. 




Cervical cancer ranks as the 2nd leading cause of cancer 
among Filipino women (Bruni et al., 2019). There are several 
risk factors attributed to the development of cervical cancer, 
however. According to the HPV Information Centre, 70% of 
cervical cancer cases worldwide are caused by the human 
papillomavirus also known as HPV, specifically types 16 and 
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18, which can be transmitted through sexual contact with an 
individual who is infected with the virus. Because of this, the 
HPV vaccine was created to protect people against HPV types 
16 and 18, HPV types 6 and 11 which cause 90% of genital 
warts cases, and HPV types 31, 33, 45, 52, and 58 which can 
lead to cervical cancer, anal cancer, vaginal cancer, penile 
cancer, and throat cancer (National Cancer Institute). 
Specifically, HPV vaccines stimulate the body to produce 
antibodies that prevent the virus from infecting other cells as it 
binds to it whenever the body comes in contact with HPV. As 
recommended by the World Health Organization (WHO), 
young adolescent girls, specifically ages 9-14 years old are 
encouraged to be vaccinated before becoming sexually active 
as this vaccine would be most effective to those who have not 
been previously exposed to the virus. The vaccine is 
recommended to be given in a series of shots wherein it is given 
in 3 separate shots for individuals who are of 15-45 years of 
age. The second shot is given 2 months after the first shot while 
the third shot is given 4 months after the second shot. For people 
ages 9-14, on the other hand, are expected to receive 2 shots. 
The second shot is given 6 months after the first shot (Centers 
for Disease Control and Prevention). 15 With this in mind, the 
Centers for Disease Control and Prevention (CDC) stated that 
getting vaccinated for the Human Papillomavirus is a very safe 
and highly effective method for the prevention of the disease as 
more than 120 million doses of the vaccine have already been 
administered in the United States since it was established in the 
year 2006. In fact, Bruni et.al had estimated that in 2019, about 
15% of girls and 4% of boys had been vaccinated with the full 
course of vaccine globally. On the other hand, they had also 
estimated that about 20% and 5% of girls and boys respectively 
had received at least one dose respectively. In the case of the 
Philippines, on the other hand, in 2016, the Department of 
Health (DOH) included the HPV vaccine as part of their 
National Immunization Program and has launched a school-
based HPV vaccination program which enables the HPV 
vaccine to be readily available to female students. Despite the 
vaccine being made available in the Philippines, women still 
die from and are being diagnosed with cervical cancer every 
year as the numbers are estimated to be at 4088 and 7190 
respectively as predicted by ICO/IARC in 2019. This may be 
due to a lot of factors. In fact, a very significant factor in 
implementing a vaccination program related to HPV and 
cervical cancer is the acceptance of the vaccine from the target 
population (Dwi Endarti et.al., 2017). In addition to that, the 
World Health Organization (WHO) in 2014 stated the 
importance of increasing the knowledge and awareness of 
cervical cancer prevention in order to achieve a successful 
program implementation. That being said, it is best to know that 
knowledge is a collection of various things such as appropriate 
information, experience, and skilled insight. These things, in 
turn, offer a person a structure for them to be able to estimate 
and integrate new experiences as well as new information 
(Mohajan, 2016). In relation to this, Cvjetkovic, et.al (2017) 
presumed that with better knowledge about immunization 
comes a 16 positive attitude based on the theory that one of the 
crucial sources of attitude is said to be cognitive information 
regarding the target topic. With that, this study aimed to 
determine the level of knowledge of the women ages 25-35 
permanently residing in Metro Manila and observe if this would 
have any effect on their decision to be immunized with the HPV 
vaccine. Furthermore, with this study, the information drive for 
doctors regarding both HPV and cervical cancer can be 
bolstered so that further awareness and prevention of these 
diseases and the risk factors that lead up to it can be promoted 
and prioritized more. 
II. THEORETICAL STUDIES 
This study was based on the theory that knowledge 
and beliefs regarding vaccines is a contributing factor, which 
influences the attitude towards vaccination and the intention of 
an individual to be immunized (Handy L.K., et al. 2017). 
According to Cvjetkovic S.J., et al (2017), better knowledge on 
immunization would project increased positive attitudes on 
vaccine acceptance. Thus, this presumption necessitates 
sufficient and appropriate education regarding a specific topic 
in order to direct a positive attitude towards the aforementioned. 
Various correlational studies that indicate positive and negative 
perceptions towards HPV vaccine further strengthen this 
theory. Multiple studies have shown that knowledge is 
significantly associated with vaccine acceptance. Several 
studies state that higher knowledge about Human 
Papillomavirus and HPV vaccination is significantly associated 
with increased willingness to be vaccinated (Chang, I., et al., 
2013 & Oz, M., et.al., 2018). On the other hand, low vaccine 
acceptance can be attributed to factors such as lack of 
knowledge about the disease as well as lack of knowledge on 
the safety profile and efficacy of HPV vaccine (Lopez, N., et 
al., 2020). With these related studies as a framework, the 
researchers want to determine if there is a significant 
relationship that exists between the level of knowledge of the 
subjects on Human Papillomavirus and cervical cancer and 
their willingness to be vaccinated against HPV. As future 
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medical professionals, this correlational research would be a 
beneficial foundation as a basis for further related studies in 
HPV vaccine hesitancy.  
III. METHODOLOGY 
  A. Research Design  
 This study utilized a correlational approach in 
collecting and analyzing data. The researchers have defined the 
extent of knowledge of women ages 25-35 on the Human 
Papillomavirus (HPV) vaccine and Cervical cancer as the 
exposure variable and the disposition of women ages 25-35 on 
their willingness to be immunized with the Human 
Papillomavirus (HPV) vaccine as the outcome variable. In 
relation to the study, the knowledge of 25–35-year-old females 
residing in Metro Manila regarding the Human Papillomavirus 
and cervical cancer and their willingness to acquire the HPV 
vaccine was used as the primary data. The correlational 
approach allowed the researchers to determine the possible 
relationship between the exposure and outcome variables. An 
online survey through Google forms was used to gather the data 
needed to address the research problem and objectives. The 
questionnaire was adapted by the researchers from existing 
online surveys from different journals to gather data needed for 
the study. The respondents of the survey consisted of women 
who are within the specific parameters, which include the age 
range of 25 to 35 years old. The survey was deployed online 
and was disseminated among women who are residing in Metro 
Manila. In addition, the survey was deployed through different 
social media platforms such as Facebook, Instagram, Discord, 
and Twitter. Quantitative data was collected from all the 
respondents and were interpreted statistically to get results.  
  B. Subject and study site  
 The sampling technique conducted in this study is 
convenience sampling, which was used in the selection of the 
respondents. The population was selected primarily based on 
their availability as well as their ability to access the online 
survey. Furthermore, the researchers chose the sample 
according to the eligibility of the participant based on the 
inclusion and exclusion criteria. Inclusion Criteria: - Healthy, 
Filipino women - Within the age range of 25-35 years old - 
Permanent residents of Metro Manila Exclusion Criteria: - 
Women residing outside Metro Manila - Cancer patients - 
Medical professionals - Women who are already vaccinated 
with the HPV vaccine the criteria for withdrawal, on the other 
hand, included those who do not wish to further participate in 
the study. The respondents participated in the study through an 
online survey deployed using different social media platforms 
such as Facebook, Instagram, and Twitter. In addition, the 
surveys contained various questions that aided the researchers 
in data gathering. Even though the data gathering would be 
conducted online, the study site of the research was located in 
Metro Manila, where the chosen respondents are permanently 
residing. Metro Manila was chosen as the study site for this 
research because the PCS-MRC in Metro manila is considered 
as the lead organization that is partnered with DOH in terms of 
the Cancer incidence, survival as well as the implementation of 
cancer control programs in the Philippines hence, the data on 
cervical cancer as well as HPV immunization has been made 
accessible for the researchers. In determining the minimum 
number of respondents required, a related study done by 
Ning et al., (2019) was used as a reference to determine the 
sample size.  
The formula that was used may be seen below:  
nr = 4pq / d2  
nr = required sample size  
4 = rounded Z 2 value of 1.96 at 95% confidence level  
p = proportion of the population having the characteristic; in 
Ning et al. 2020, 20% knew about HPV Vaccine = 0.20  
q = 1- p = 1 - 0.20 = 0.80  
d = the degree of precision (margin of error); set at 10%  
nr = 4 * 0.20 * 0.80 / (0.1)2 = 0.64 /0.01 = 64 
  C. Data measure/instrumentation 
 The researchers applied the method of convenience 
sampling in gathering the respondents for the reason that the 
selection of the target population was more convenient for the 
group considering the constraints brought upon by the 
pandemic. For the instrumentation, the researchers utilized a 
survey questionnaire as a tool to determine the knowledge of 
women on HPV and Cervical cancer and its correlation to their 
willingness to procure the HPV vaccine. The survey was further 
divided into four sections, which were written in both English 
and Filipino language. The sections of the questionnaire were 
focused on the personal consent of the respondent, the socio-
demographic portion, knowledge part regarding HPV, Cervical 
Cancer, and the HPV Vaccine, and the Disposition on HPV 
immunization. The survey deployed was a guided-response-
type of questionnaire that allowed the participants to respond 
on polar type of questions that were answerable by true or false, 
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in which the “correct” answer corresponded to 1 while the 
“incorrect” answer is coded as 0. This format was observed 
throughout the knowledge part of the survey while the consent 
and Disposition on HPV Immunization was answerable by yes 
or no. The sociodemographic part, on the other hand, was 
answered through a multi select type of choices. The knowledge 
of the participants is evaluated by utilizing a composite score. 
If the participants have scored a composite score of greater than 
or equal to 50%, the participants were considered to be 
knowledgeable (Gatumo et al., 2018). The questionnaire 
consisted of questions that were adapted from the studies of 
Gatumo, et al. (2018), Mbachu C., Dim C., and Ezeoke U. 
(2017), Sherman S. M., et al. (2018), and Xue L., et al. (2017). 
However, other questions from those studies were not included 
in the survey for the reason that these questions were not related 
anymore to the study at hand.  
 The adapted questionnaire from the aforementioned 
multiple studies were validated through face validity wherein 
the survey questions were peer reviewed by experts. This 
measure was done to ensure that the questions included in the 
survey are well structured, appropriate and within the scope of 
the study. These experts included members of specialist doctors 
from Antique Medical Center and Anghel Salazar Memorial 
General Hospital. For ethical concerns, the questions that were 
conveyed in the survey were consulted with the research ethics 
committee.  
 Consent Section. The survey allotted a consent section 
for the purpose of obtaining informed consent among its 
respondents. This section involved questions regarding the 
voluntary participation of the respondent in the study. In 
addition, the respondents were asked for permission to use the 
data generated from this survey according to the researcher’s 
purpose and nature of the study.  
 Socio-demographic section. The questionnaire from 
this segment was adapted from the study of Gatumo, M., 
Gacheri, S., Sayed, AR. et al. (2018), Mbachu C., Dim C., and 
Ezeoke U. (2017), Sherman S. M., et al. (2018), and Xue L., et 
al. (2017). This part included survey questions about basic 
socio-demographic information such as name of the respondent 
(optional), age, civil status, and parity. Objective questions on 
multiple pregnancy were inquired in this section to further 
determine the associated risk factors of HPV vaccination and 
Cervical cancer. The queries included in this survey section 
were in multiple choice. 
 Knowledge Section. This part consisted of questions 
adapted from the study of Sherman S. M., et al. (2018) and 
Gatumo, M., Gacheri, S., Sayed, AR. et al. (2018), which 
pertained to the level of knowledge and awareness of the 
respondents on HPV, Cervical cancer, and HPV vaccination. 
The questions ranged from general to some in-depth 
information about the aforementioned in order to assess the 
participants’ extent of knowledge about the topic of the study. 
This section contained questions answerable by true or false.  
 Disposition on HPV Immunization. This section 
included the final question that assessed the disposition or 
willingness of the respondents to be immunized with HPV 
vaccine. The question was adapted from the study of Xue L., et 
al. (2017). With that, the researchers administered the survey 
on selected women who met the specific criteria as eligible 
respondents of the study. The survey was deployed online by 
utilizing Google forms at its main platform of dissemination 
and was shared through different social media platforms such 
as Facebook, Instagram, and Twitter as well as Discord.  
  D. Data gathering procedure  
 The researchers have asked for the approval of the 
ethics review board in line with the ethical considerations of the 
study. Upon approval, the researchers started to disseminate the 
survey forms. Considering the current situation, with the on-
going pandemic, data gathering process was done through a 
Google Form link that has been sent out. Selection of 
participants was done through convenience sampling. Forms 
were shared through different social media platforms by posting 
on different Facebook research groups as well on Discord 
servers, Twitter posts, and Instagram stories. The 
questionnaires were answered by willing participants that 
belong to the inclusion criteria.  
 The whole data gathering process was conducted in a 
span of a month. In the Google Form, the researchers have 
emphasized the purpose and the significance of the study 
including the possible risks in answering the survey. An 
informed consent for the participants' permission to continue on 
with the survey was also included in the form. The forms were 
strictly answered by the willing participants that had met the 
inclusion criteria for this study. Researchers have officially 
closed the form and ended the data gathering process when the 
total number of responses counted has already met the 
designated sample size for the study.  
  E. Ethical considerations 
 The researchers devised a survey form in which the 
purpose of such was explained in full detail in order to inform 
the subjects of the implications of answering the survey. In 
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addition, the survey was accompanied with a consent form for 
subjects to fill out before continuing on to the actual survey 
questions. People who were deemed fit to be subjects in the 
study were not barred from participating in the survey unless 
the existing exclusion criteria matched them. The identities of 
the subjects were kept confidential. The identities were only 
shared between the researchers and the subjects involved 
through coding measures. The survey did not require the 
subjects to undergo any tasks and was purely answered 
voluntarily by the subjects without any stipends nor monetary 
exchange. The researchers did not practice any biases in 
conducting the study wherein all results that were generated 
from the study was only based on the data that was gathered 
from the surveys conducted online.  
  F. Data analysis  
 Data gathered were encoded in Microsoft Excel and 
were analyzed using a software called IBM Statistical Package 
for Social Science (SPSS) through descriptive and correlational 
statistical methods in which the alpha level was set at 0.05. 
Descriptive statistics was utilized to analyze all the data 
collected showing the number of responses, percentages, the 
mean and standard deviation of the participant’s age and the 
scores that they have attained for each section.  
 In addition to that, Spearman’s rho correlation 
coefficient was utilized to investigate the relationship between 
the level of knowledge of women ages 25-35 residing in Metro 
Manila on HPV and cervical cancer and their willingness to be 
vaccinated with the HPV vaccine. Spearman’s rho correlation 
coefficient, a nonparametric test, was found to be more 
appropriate in analyzing the data for this study as compared to 
Pearson’s correlation coefficient because of the consideration 
that the data collected was categorical, specifically the ‘true’ or 
‘false’ and the ‘yes’ or ‘no’ choices while Pearson’s correlation 
coefficient uses continuous data. 
IV. RESULTS AND DISCUSSION 
  A. Results 
 Socio-demographic: 
Overall, a total of 86 responses were gathered but 21 
participants were excluded for not being able to meet some of 
the inclusion criteria. Specifically, the excluded participants 
were not residing in Metro Manila or did not meet the age range 
of 25-35 years. Another reason for the exclusion is because 
other participants have already been vaccinated or are working 
in the field of medicine. With the consideration of the inclusion 
and exclusion criteria, a total of 65 respondents are used in the 
study to assess their level of knowledge with regards to Human 
Papilloma Virus (HPV). 
Table.1. Sociodemographic profile of the respondents (n=65) 
Characteristics n (%) 
Age in years, mean (SD) 28.4 3.2 
Marital Status   
      Single 56 86.2 
      Married 9 13.8 
Parity (Number of 
Pregnancies) 
 
0 51 78.5 
1 8 12.3 
2 4 6.2 
3 2 3.1 
Number of children  
0 51 78.5 
1 9 13.9 
2 4 6.2 
3 1 1.5 
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Employed/Self-employed 58 89.3 
Housewife 1 1.5 
Student 4 6.2 
Unemployed 2 3.1 
City Residence  
Caloocan 1 1.5 
Las Pinas 3 4.6 
Makati 6 9.2 
Mandaluyong 2 3.1 
Manila 15 23.1 
Marikina 2 3.1 
Muntinlupa 6 9.2 
Paranaque 4 6.2 
Pasig 3 4.6 
Quezon 17 26.2 
San Juan 2 3.1 
Taguig 4 6.2 
 
 Table.1. shows that the mean average Age computed 
for a total of 65 respondents is 28.4 years. Out of the 65 
participants who have completed the survey, the marital status 
of the majority of the participants are single (86.2%). On parity, 
the highest percentage of the respondents show that 78.5% had 
0 number of pregnancies. In addition, the results on the number 
of children indicate that 78.5% of the participants have no 
children. Furthermore, on occupation, a total of 89.3% of the 
respondents are either employed or self-employed. The 
statistics on the characteristics of the participants based on their 
permanent residence show that most of the respondents reside 
in Quezon City (26.2%). 
Knowledge on HPV, Cervical Cancer and HPV Vaccine: 
Table.2. HPV, Cervical cancer and HPV vaccine knowledge questions. 
 Correct  
Response  
N (%) 
HPV Knowledge and Awareness  
HPV can cause cervical cancer 54 (83.1) 
Having many sexual partners increase the risk 
of getting HPV 
62 (95.4) 
HPV can be passed on during sexual 
intercourse 
55 (84.6) 
A person could have HPV for many years 
without knowing it 
61 (93.8) 
HPV always has a visible signs and 
symptoms 
45 (69.2) 
HPV is very rare 52 (80.0) 
There are many types of HPV 59 (90.7) 
Men cannot get HPV 53 (81.5) 
Using condoms reduces the risk of getting 
HPV 
52 (80.0) 
HPV can be passed on by genital skin-to-skin 
contact 
45 (69.2) 
HPV can be cured with antibiotics 44 (67.7) 
HPV can cause HIV/AIDS 25 (38.5) 
HPV can cause genital warts 59 (90.7) 
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Most sexually active people will get HPV at 
some point in their lives 
45 (67.7) 
Having sex at an early age increases the risk 
getting HPV 
47 (72.3) 
HPV usually doesn’t need any treatment 17 (26.2) 
Cervical Cancer Knowledge and 
Awareness  
Cervical cancer is preventable 63 (96.9) 
Having many different sexual partners is a 
risk for cervical cancer 
50 (76.9) 
Oral contraception is a risk factor for cervical 
cancer 
29 (44.6) 
Smoking is a risk factor for cervical cancer 48 (73.8) 
HIV is a risk factor for cervical cancer 50 (76.9) 
Cervical cancer is more likely to be diagnosed 
when you have a family history of cervical 
cancer 
56 (86.2) 
Giving birth to many babies is a risk factor for 
cervical cancer 
24 (36.9) 
HPV is a risk for cervical cancer  56 (86.2) 
HPV Vaccine Knowledge and Awareness  
The HPV vaccines are most effective if given 
to people who have never had sexual 
intercourse  
34 (52.3) 
The HPV vaccine offers protection against 
most cervical cancers  
60 (92.3) 
Someone who previously had HPV vaccine 
cannot develop cervical cancer  
49 (75.4) 
The HPV vaccine offers protection against 
genital warts 
52 (80.0) 
The HPV vaccine offers protection against all 
sexually transmitted infections 
31 (47.7) 
The recommended vaccine doses is three 32 (49.2) 
Women who previously had the HPV vaccine 
do not need to undergo smear test in the future 
61 (93.8) 
 
Shown in Table.2, the total number and percentage of 
respondents who were able to answer correctly in each question 
listed. The researchers, with the help of a statistician, had 
computed the mean scores of the participants in each part. 
Those who had a composite score of greater than or equal to 
50% were considered to be knowledgeable. In the 16-point set 
of questions about HPV knowledge and awareness, the mean 
score of the participants is 11.9 (± 2.2). From the results of the 
participants in this part of the survey, it is noted that 64 had 
gotten at least 8 items correct hence it can be said that 98.5% of 
the respondents are considered to be knowledgeable about 
HPV.  In the case of the participants’ knowledge and awareness 
of Cervical Cancer, the mean score in the eight-point 
questionnaire is 5.8 (± 1.5). For the HPV vaccine knowledge 
and awareness, the mean score in the seven-item survey is 4.9 
(± 1.1). From this, it can be said that 93.8% and 84.6% of the 
respondents are considered knowledgeable in cervical cancer 
and in HPV vaccine respectively the respondents had garnered 
a minimum of four points and above in the sections of the 
questionnaire on cervical cancer and HPV vaccine. 
Disposition on HPV Vaccination: 
Figure.2. Willingness to take the HPV vaccine 
 
Fig.2. shows that a total of 63 or 96.9% of the respondents are willing 
to be immunized with the HPV vaccine.  
Correlation:  
 The data collected from the survey was subjected to 
statistical analysis using Spearman’s Rank Order Correlation 
since the data gathered is considered as categorical data 
wherein questions in the survey were answerable by either 
“True” or “False”. The analysis was done in order to assess the 
correlation between the level of knowledge of the participants 
on HPV, Cervical Cancer, and HPV vaccine and their 
disposition on getting vaccinated against HPV.  
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Table.3. Spearman’s Rank Order Correlation between the level of 
knowledge and awareness of respondents and their disposition on HPV 
immunization (n=65) 
 Willingnes







































** Correlation is significant at the 0.01 level (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed) 
 Table.3. shows the results of the statistical analysis 
using Spearman’s rho correlation. From the results, it can be 
seen that the p-values calculated from each section of the survey 
regarding knowledge and awareness on HPV, Cervical Cancer, 
and HPV Vaccine were not significant. With this, it can be 
inferred there is no correlation between HPV knowledge and 
awareness and the willingness of the participants to get 
vaccinated (rs = .127, p = .312). Similarly, there is no 
correlation existing as well between the knowledge and 
awareness on cervical cancer and the participants’ inclination 
to get inoculated with the HPV vaccine (rs = .225, p = .072). 
There is also no correlation found between HPV vaccine 
knowledge and awareness, and the disposition of the 
respondents to get HPV inoculation (rs = .178, p = .157). 
  B. Discussion 
Socio-demographic factors: 
In this study, 65 out of 86 respondents were included while 21 
respondents were excluded due to not being able to adhere to 
the inclusion criteria. As the researchers assess the knowledge 
of the respondents, sociodemographic factors were also 
reviewed since they contribute to the prevalence of Human 
papillomavirus and cervical cancer and can also influence the 
willingness of participants to acquire HPV vaccination. 
 Age is one of the significant factors of HPV infection 
and cervical cancer as it can be an indicator of prevalence. This 
can also be a predisposing factor to HPV vaccine acceptance. 
Young women more than 18 years of age are more likely to 
have HPV infection while older women have less prevalence 
than younger women. This is said in a study by Andersen, B., 
et al. in 2019 and the study reports that the prevalence of HPV 
decreases slightly as the age increases. This pattern of 
decreased prevalence can also be seen in a study by Krashias, 
G., et al. in 2017, which tested 596 women for HPV prevalence 
and type distribution. It stated that the HPV prevalence is 
dependent on age and this prevalence decreases until the age of 
45 years. Its results show that the highest prevalence is seen in 
women ages 25 and below, followed by women ages 26 – 35 as 
well as women ages 46 and below and lastly, the lowest 
prevalence is seen in women who are within the ages of 36 – 45 
years old. Additionally, in a study by Brotherton, J. M., et al. in 
2019, an HPV based cervical screening was conducted among 
116, 052 women ages 25 – 74, its results showed that HPV 
prevalence reaches its peak at the ages of 25 – 29. In the 
researchers’ study, the results show that the mean age of the 
participants is 28.4, which is within the age range of peak 
prevalence, which can impact their disposition on HPV 
immunization.  
  In the survey conducted by the researchers, the 
majority (86.2%) of the respondents are married while 13.8% 
are single. Relationship status is another sociodemographic 
factor which is to be considered. Although there are no known 
studies that correlate relationship status and HPV prevalence, it 
can be associated with HPV vaccination uptake and various 
studies assess the impact of relationship status on vaccination. 
A study by Thompson, E., et.al. in 2016 stated that women 
living with a partner and single women have more interest in 
HPV vaccine than married women. Furthermore, in another 
study by Thompson, E., et al in 2019, women in committed 
relationships see themselves as having low risk for HPV. 
However, another study conducted a study regarding HPV 
infection in early pregnancy and the results show that in the 
population, women with longer married life as well as high 
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BMI are more frequently confirmed with HPV positive status, 
which can have an indirect correlation with years of sexual 
activity (Pandey, D. et al., 2019). Based on the studies, the 
relationship status of the participants may be a factor to their 
decision to avail vaccination as majority of the participants 
have chosen ‘Yes’ on their disposition on HPV immunization.  
 Majority of the respondents in this study have no 
pregnancies while others have one (12.3%), two (6.2%) and 
three (3.1%) number of pregnancies, respectively.  Parity can 
also be associated since HPV can be presented in early 
pregnancy due to changed hormonal milieu and immune 
response. HPV infection can also be attributed to preeclampsia, 
placental abnormalities, preterm deliveries and other pregnancy 
adverse outcomes (Pradhan, S. R., et al., 2020). In study by 
Pandey, D., et al. in 2019, the researchers discussed about HPV 
infection in early pregnancy, the results have shown that in 
African pregnant women, the prevalence of HPV DNA was 
33.3% and the researchers also mentioned that in Brazil, there 
is a higher prevalence of HPV in pregnant women as compared 
to non-pregnant women. As there are participants in the study 
who have multiple pregnancies, parity may play a role in their 
willingness to be vaccinated.  
  Lastly, it has been stated in this study that 
sociodemographic factors such as employment and residential 
setting can affect HPV knowledge and awareness of 
participants. This can be supported by a study conducted by 
Cimke, V. S., et al. in 2019 as they conducted interviews with 
753 women in various professions regarding early diagnosis of 
cervical cancer. In the study, the researchers stated women who 
have good education and income level and women who live in 
the city are considered as knowledgeable in HPV, HPV 
vaccination, Pap smear test, and cervical cancer. The study 
reported that doctors have the highest knowledge level while 
homemakers have the lowest. Although, in another study which 
consists of homemakers and unqualified workers as 
participants, it produced higher results than the previous study 
mentioned (Raychaudhuri & Mandal, 2012). In our study, 
employment can be considered as a factor in willingness to be 
vaccinated since the majority of our participants are employed 
which could mean that they have possible financial capability 
as well as an educational attainment. However, income level 
and educational attainment were not included in our study and 
could be further investigated in future studies regarding their 
association in the participants’ willingness to be vaccinated. 
The focus of the researchers’ study are respondents living in 
Metro Manila, which is the largest urban area in the Philippines. 
Residential setting is also considered as a factor associated with 
HPV and HPV vaccine knowledge, as shown in a study by 
Fernández-Feito, A., et.al. in 2020, which conducted a 
questionnaire among a sample of Spanish women and analyzed 
their level of knowledge in relation to education level and 
residential setting. The results stated that women living in rural 
areas are associated with having little or no knowledge whereas, 
women who are living in more urban areas are associated with 
having more knowledge about HPV infection and HPV 
vaccine. Based on this study, it can be inferred that the 
participants in the study may be knowledgeable since they live 
in an urban area.  
 In this study, the researchers focused more on the level 
of knowledge of the respondents on HPV, cervical cancer and 
HPV vaccine and its association to the respondents’ willingness 
to be immunized with HPV vaccine. The sociodemographic 
factors were only identified as predisposing indicators that may 
influence the rate of HPV vaccine acceptance among the 
respondents.  
Knowledge on HPV, Cervical Cancer and HPV Vaccine: 
 Furthermore, the findings in this study showed that 
93.8% of our respondents are knowledgeable in cervical cancer 
and 84.6% of the respondents are knowledgeable in HPV 
vaccine. This is based on the criteria that the respondent must 
have a composite score greater than or equal 50% in order to be 
considered as knowledgeable. The focus of this study is on the 
correlation of the level of knowledge on HPV, cervical cancer 
and HPV vaccine and the willingness of the participants to be 
immunized with HPV vaccine. Many studies show that 
knowledge level significantly impacts the disposition on HPV 
immunization. Different studies report varying results in 
regards to the association of knowledge and HPV 
immunization. A study by Oz, M., et al. in 2018 reports the high 
knowledge levels are related to increased willingness to be 
vaccinated. On the other hand, a study by Lee, Y. M., et al. in 
2018 shows that lack of knowledge about HPV as well as 
negative perceptions on HPV vaccination becomes a barrier in 
appropriate information and this lowers vaccination rates. 
These studies strengthen the association of level of knowledge 
and the willingness to be vaccinated. 
Willingness to take the HPV vaccine: 
 In accordance with the conducted survey on the 
willingness of women aged 25-35 with regards to taking the 
HPV vaccine, its results show that the majority of the 
respondents, which comprised of 96.9% of the total 
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respondents, showed willingness to be immunized with the 
vaccine if it is available, while 3.1% respondents expressed 
their hesitancy in acquiring the said vaccine as per the results 
of the conducted online survey. Vaccine hesitancy is an arising 
global concern wherein the public refuses vaccine inoculation 
despite its availability which is commonly influenced by factors 
such as complacency, overconfidence, and unawareness. 
Accordingly, this attitude is observed in the topic of HPV 
vaccination in several studies. A study done by Dwi Endarti 
et.al. (2018) determined that women in Yogyakarta Province in 
Indonesia perceive HPV vaccination in a negative manner due 
to the price of the vaccine and the lack of information regarding 
the HPV and cervical cancer. Results of the study also showed 
a low percentage of vaccinated individuals among the 
population used by the researchers. A study conducted by 
Decena & Benavides (2017) also expounded the different 
factors that hinders obstetrics and gynecology residents in 
prescribing and vaccinating their patients. The most common 
reasons include safety concerns and lack of information as well.  
 Despite the growing hesitancy among the public, 
several studies have shown that communities still exhibit a high 
acceptance rate of acquiring the HPV vaccine, which is 
reflected by the results garnered in this study. The finding of a 
high acceptance rate is similar to the result of the research done 
by Dwi Endarti et.al. (2018) wherein 92% of female 
adolescents, 90% of adult women, and 91% of parents included 
in the population were willing to take the HPV vaccine. Despite 
the unsatisfactory level of knowledge and awareness of the 
participants regarding HPV and cervical cancer, an opposite 
reaction from the participants was observed when asked if they 
are willing to be vaccinated. Based on the data the authors 
acquired from the survey, the efficacy of HPV vaccine and 
screening was the main factor that enhanced the acceptance of 
the respondents to the said vaccine. The results from the study 
by He & He (2016) are comparable with the finding of a high 
acceptance rate since half of the respondents in the Health 
Management Center of West China Hospital of Sichuan 
University were willing to take the HPV vaccine upon 
awareness of its effectiveness against HPV infection. The 
authors of the study concluded that the willingness of the 
respondents rely upon their age and family history of cervical 
cancer where women aged 18-29 and women with known 
history are more accepting. Another study that demonstrated a 
high acceptance rate of the vaccine in a certain population was 
done by Baloch et al. (2017). The study was conducted in 
Yunnan Province, China and the researchers recruited women 
who frequent the outpatient department of the First People’s 
Hospital of Yunnan. 38% of the participants were aged 31-40 
who are mostly married and with children. The results featured 
a low awareness regarding the availability of the vaccine, 
however, the majority of the participants at 82.7% were willing 
to vaccinate their children when they are of age. A study 
conducted by Zhang et al. (2020) also exhibited a high 
acceptance rate of HPV vaccination among Chinese 
adolescents studying in urban and rural schools. Out of the 
4,062 respondents, 2,733 were willing to be vaccinated with the 
HPV vaccine wherein 72.6% are female Chinese students.  
 The respondents of this study are healthy women aged 
25-35 who permanently reside in Metro Manila. Health-allied 
professionals, cancer patients, and women who are already 
vaccinated with the HPV vaccine are excluded from the study. 
The researchers did not expound on the factors that can be 
significantly associated with the willingness of the respondents 
to have the vaccine. However, potential relationships between 
the inclusion criteria of the target population and the 
acceptability of the respondents can be further investigated in 
future studies. The possible determinants that resulted in a 
96.9% acceptance rate of the vaccine which are not stated in the 
inclusion criteria are most likely the educational attainment, 
knowledge about the efficacy and safety of vaccines, frequency 
of sexual activity, and recommendations from different sources 
such as doctors, family, and peers. Further studies regarding 
these factors should be done to gain sufficient data to establish 
a rationale pertaining to the high acceptance rate of the 
respondents. 
 Regardless of the high level of willingness of the 
participants to receive the vaccine, the researchers acknowledge 
the limitations of the study that may have partaken in the 
outcome of the results. The 65 respondents from this study 
cannot represent the totality of women aged 25-35 living in 
Metro Manila since convenience sampling was utilized. Aside 
from the method of sampling, online surveys also hinder 
possible respondents from answering the survey since it is 
inaccessible to those who lack internet connectivity and are 
unfamiliar with the use of Google Forms and e-mails. Further 
studies may be done to address the limitations mentioned 
above.  
Correlation:  
 The researchers proposed to correlate the data on the 
level of knowledge of the respondents to their disposition on 
HPV immunization which was obtained from the conducted 
survey. Although the level of knowledge of the participants 
regarding HPV, Cervical Cancer, and HPV vaccination as well 
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as the willingness to vaccinate were considerably high, a 
correlation between these two variables were found to be 
insignificant. Determining the relationship between knowledge 
and choice is a frequent topic of study in the fields of 
psychology and behaviour. A theory by Handy et al. (2017) 
stated that knowledge and beliefs directly affect the attitude and 
intention of a person towards the idea of vaccination. The 
researchers established the main objective of this study in order 
to investigate whether this idea is applicable with HPV 
knowledge and vaccine.  
 Various studies also tested the association between 
these two variables and came to a conclusion based on the data 
they acquired. These studies showed no correlation or 
relationship between the level of knowledge and willingness or 
attitude of the participants to the vaccine, which is significantly 
observed in the study. Comparable to the findings of the study 
is research done by Zouheir et al. (2016) wherein the data 
presented suggests that knowledge about HPV did not have a 
significant impact or association with vaccine acceptance. The 
level of knowledge from the respondents who were mainly 
adolescents and young adults were found to be unsatisfactory 
as well as the acceptance of the HPV vaccine despite the high 
prevalence of this disease in Morocco.  The authors suggested 
that the low levels of these variables are most likely because of 
the predominant culture present in Morocco. Moroccan culture 
is deemed to be more sexually conservative as compared to 
western countries, hence, topics such as HPV and HPV 
vaccination is considered a taboo topic, affecting the 
knowledge and awareness of young adults (Zouheir et al., 
2016). Association between the knowledge and attitude 
towards the HPV vaccine is also absent in the systematic review 
of Prue et al. (2016). This review focused on studies dealing 
with the knowledge and acceptance of adolescent boys towards 
HPV and HPV vaccination in the US and Europe. The authors 
established that knowledge does not predict the willingness of 
adolescent boys to have the vaccine as seen in high quality 
studies included in this review such as the study by Moss et al. 
(2015) which does not support the hypothesis about the possible 
correlation between the two variables. The results in this review 
are in line with the findings of the main study and were able to 
support the claim of Prue et al. regarding the lack of correlation, 
however, the study focused more on middle aged women rather 
than adolescent boys. Further studies with Filipino adolescents 
may be done to ensure the reliability of Prue et al.’s claims.  
 Contrarily, several studies found that there is a 
correlation between the extent of knowledge about HPV and the 
willingness to be vaccinated. Cvjetkovic et.al. (2017) stated that 
a higher level of knowledge is most likely predictive of high 
acceptability towards HPV vaccination. The authors also 
mentioned similar studies where a significant relationship is 
found between the two variables. Although, part of the 
limitations of this study is that Cvjetkovic et al. only garnered 
respondents that are students of medicine, law, and technical 
engineering from University of Belgrade in Serbia, therefore, 
the results cannot represent the total population of students who 
were members of an official online student groups. The authors 
recommended further research with a larger sample size to 
acquire more specific data. Another study showing a significant 
correlation is conducted by Adesina et.al. (2018) wherein the 
authors were able to demonstrate a relationship between HPV 
knowledge and HPV vaccine acceptability. Adesina et.al. 
concluded that the level of knowledge of mothers in Ilorin, 
Nigeria is a crucial determinant of their willingness to vaccinate 
their daughters. The possible reasons that led to this result are 
differences in prior knowledge and varying populations as 
stated by the authors. Implications were still made regarding 
HPV knowledge and vaccination despite the lack of correlation 
between the two. Adesina et.al. (2018) recommended that 
public campaigns and programs specific for HPV, Cervical 
Cancer, and HPV vaccine should be implemented in Ilorin, 
Nigeria, as well as including the vaccine to the National 
Immunization Program.  
 The researchers also acknowledge the limitations that 
may have affected the outcome of the study. A huge percentage 
of the participants responded as willing to be vaccinated in 
contrast to the 3.1% who refused the vaccination despite its 
availability. A correlation cannot be made since the difference 
between the two variables were too distant to establish a 
relationship. One of the potential factors that led to this 
outcome is the sampling method utilized by the researchers. 
Since convenience sampling was used, the respondents cannot 
represent the totality of the population regardless of the 
objectivity of the inclusion criteria. Further studies may be done 
to address the limitations mentioned above.  
V. CONCLUSION 
 The study at hand was conducted for the sole purpose 
of determining whether or not a relationship exists between the 
level of knowledge of women ages 25-35 in Metro Manila on 
HPV and cervical cancer and their decision to get immunized 
with HPV vaccine. Based on the results from the statistical 
analysis, it is evident that there was no correlation at all existing 
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between the knowledge of the respondents on HPV, Cervical 
Cancer, and HPV Vaccine and their willingness to get 
inoculated with the HPV Vaccine. The findings of this study 
suggest that most of the respondents are knowledgeable about 
HPV, cervical cancer and the HPV vaccine. In addition to this, 
the majority of the participants are also willing to take the HPV 
vaccine if it is available to them. Several limitations such as the 
sampling method utilized and the limited number of 
respondents may have contributed to the results and findings of 
the study. The results of this study may provide further insight 
regarding the current situation of the level of knowledge of 
women ages 25-35 permanently residing in Metro Manila and 
their decision to get vaccinated with the HPV vaccine. This 
study is also expected to give information that may be 
appropriate and beneficial in strengthening, promoting and 
implementing programs related to cervical cancer prevention 
and awareness. Lastly, this may be used as a reference for future 
studies in the Philippines that will discuss the relationship 
between the level of knowledge of women on HPV and 
Cervical cancer and their decision to get vaccinated. 
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